Skip to Main Content

Paper Details

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Clin Cancer Res
17
2021
Author NameAffiliation
David M NanusWeill Cornell Medical College
William R BerryDuke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University
Emmanuel S AntonarakisJohns Hopkins University
Howard I ScherWeill Cornell Medical College
Howard I ScherMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2